Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 196

Sort by

Sort Order Select

Journal Articles

Altered Angiogenic Gene Expression Profiles in Porcine Von Willebrand Disease

Mario von Depka, MD PhD, Katharina Kaiser, Carsten Detering, MSc, Mahnaz Ekhlasi-Hundrieser, PhD, Christiane Pfarrer, DVM, Prof, Stefanie Lehner, DVM, PhD

Blood (2019) 134 (Supplement_1): 4917.

https://doi.org/10.1182/blood-2019-122407

Published: 2019

Journal Articles

The MP0250-CP201 Mirror Study: A Phase 2 Study Update of MP0250 Plus Bortezomib and Dexamethasone in Relapse/Refractory Multiple Myeloma (RRMM) Patients Previously Exposed to Proteasome Inhibitors and Immunomodulatory Drugs

Norbert Grząśko, MD PhD, Stefan Knop, Hartmut Goldschmidt, MD, Marc S Raab, MD PhD, Jan Dürig, Sara Bringhen, Mattia D'Agostino, MD, Barbara Gamberi, Elena Rivolti, MD, Angelo Vacca, MD PhD, Roberto Ria, MD, Artur Jurczyszyn, MD, Jorge Castellano Acosta, MD, Doris Lang, Guy Lemaillet, PhD, Bansod Sudhir, MD, Monika Szarejko, MD

Blood (2019) 134 (Supplement_1): 1899.

https://doi.org/10.1182/blood-2019-129827

Published: 2019

Journal Articles

Subgroup Analyses from L-Mind, a Phase II Study of Tafasitamab (MOR208) Combined with Lenalidomide in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Johannes Duell, MD, Kami J. Maddocks, MD, Eva González-Barca, MD PhD, Wojciech Jurczak, MD PhD, Anna Marina Liberati, Sven de Vos, MD PhD, Zsolt Nagy, MD PhD, Aleš Obr, MD PhD, Gianluca Gaidano, MD PhD, Pau Abrisqueta, MD PhD, Marc André, Martin Dreyling, MD, Tobias F Menne, MD PhD FRCPath, Maren Dirnberger-Hertweck, PhD, Johannes Weirather, PhD, Sumeet Ambarkhane, MD MBBS, Gilles A. Salles, MD PhD

Blood (2019) 134 (Supplement_1): 1582.

https://doi.org/10.1182/blood-2019-122573

Published: 2019

Journal Articles

Venous Thromboembolism in Cancer Patients Receiving Immunotherapy

Joanna Roopkumar, MBBS, MPH, Ann S. Kim, BA, Thapa Bicky, MD, Brian P. Hobbs, PhD, Alok A. Khorana, MD

Blood (2018) 132 (Supplement 1): 2510.

https://doi.org/10.1182/blood-2018-99-116439

Published: 2018

Journal Articles

Arterial and Venous Thromboembolic Safety of Bevacizumab in Patients with High Grade Gliomas

Inyoung Lee, MS, BPharm, Sruthi Adimadhyam, BPharm, MS, Edith A. Nutescu, PharmD., MS, FCCP, Karen Sweiss, PharmD, Pritesh Patel, MD, Gregory Sampang Calip, PharmD, MPH, PhD

Blood (2018) 132 (Supplement 1): 2280.

https://doi.org/10.1182/blood-2018-99-116938

Published: 2018

Journal Articles

Pomalidomide Based Regimens for Treatment of Relapsed Multiple Myeloma: A Systematic Review and Meta-Analysis of Clinical Trials

Adeela Mushtaq, MD, Ahmad Iftikhar, MD, Midhat Lakhani, MD, Fnu Sagar, MD, Ahmad Kamal, MD, Umar Zahid, MD MPH, Hamza Hassan, MD, Zeeshan Ali, MD, Faryal Razzaq, MBBS, Saad Ullah Malik, MD, Syeda Fatima Hassan, MBBS, Muhammad Abu Zar, MD, Mohammad Bilal Chaudhary, MD, Ahmad Safdar, Mohamed Mokhtar Bakr, MD, Faiz Anwer, MD

Blood (2018) 132 (Supplement 1): 2022.

https://doi.org/10.1182/blood-2018-99-111439

Published: 2018

Journal Articles

Single-Arm Phase II Study of MOR208 Combined with Lenalidomide in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma: L-Mind

Gilles Andre Salles, Johannes Duell, MD, Eva González-Barca, MD PhD, Wojciech Jurczak, MDPhD, Anna Marina Liberati, MD, Zsolt Nagy, MD PhD, Aleš Obr, MD, Gianluca Gaidano, MD PhD, Marc Andre, MDPhD, Nagesh Kalakonda, MD, Martin Dreyling, MD PhD, Pier Luigi Zinzani, MD, Maren Dirnberger-Hertweck, PhD, Johannes Weirather, PhD, Sumeet Ambarkhane, MD MBBS, Kami J. Maddocks, MD

Blood (2018) 132 (Supplement 1): 227.

https://doi.org/10.1182/blood-2018-99-113399

Published: 2018

Journal Articles

Single-Arm Phase II Study of MOR208 Combined with Lenalidomide in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma: L-Mind

Gilles Andre Salles, MD PhD, Johannes Duell, MD, Eva González-Barca, MD PhD, Wojciech Jurczak, PhDMD, Anna Marina Liberati, MD, Zsolt Nagy, MD PhD, Tomáš Papajik, MD PhD, Gianluca Gaidano, MD PhD, Marc Andre, MD, Nagesh Kalakonda, MD, Martin Dreyling, MD PhD, Pier Luigi Zinzani, MD, Sumeet Ambarkhane, MD, Johannes Weirather, PhD, Maren Dirnberger-Hertweck, PhD, Kami J. Maddocks, MD

Blood (2017) 130 (Supplement 1): 4123.

https://doi.org/10.1182/blood.V130.Suppl_1.4123.4123

Published: 2017

Journal Articles

Role of Platelets in Adaptive Changes to Anti-Angiogenesis Therapy

Anil Sood, MD

Blood (2017) 130 (Supplement 1): SCI-27.

https://doi.org/10.1182/blood.V130.Suppl_1.SCI-27.SCI-27

Published: 2017

Journal Articles

Thrombospondin-1 Induces Apoptosis in Megakaryocytic Leukemia Via CD36 and Caspase-3 Signaling

Mo Yang, PhD, Enyu Liang, MB, Lijing Mao, MB, Beng H Chong, PhD, Chunfu Li, MD

Blood (2016) 128 (22): 5209.

https://doi.org/10.1182/blood.V128.22.5209.5209

Published: 2016

Journal Articles

VEGF , VEGFR2 and GSTM1 polymorphisms in Outcome of Multiple Myeloma Patients in the Thalidomide Era

Leisa Lopes-Aguiar, Marcia Torresan Delamain, Angelo Borsarelli Carvalho Brito, Gustavo Jacob Lourenço, Ericka Francislaine Dias Costa, Gislaine Borba Oliveira, Jose Vassallo, Carmino Antônio De Souza, MD PhD, Carmen Silvia Passos Lima

Blood (2016) 128 (22): 4457.

https://doi.org/10.1182/blood.V128.22.4457.4457

Published: 2016

Journal Articles

Treatment of Hodgkin Lymphoma Xenografts with the Novel PI3K δ/γ Inhibitor RP6530 Suppresses M2 Macrophage Polarization and Results in Potent Antitumor and Antiangiogenic Effects

Silvia Laura Locatelli, PhD, Francesca Maria Consonni, Giuseppa Careddu, Simone Serio, Srikant Viswanadha, PhD, Swaroop Vakkalanka, PhD, Luca Castagna, MD, Armando Santoro, MD, Carmelo Carlo-Stella, MD

Blood (2016) 128 (22): 45.

https://doi.org/10.1182/blood.V128.22.45.45

Published: 2016

Journal Articles

The Role of the Slit-Robo Family in Adult Patients with Acute Myeloid Leukemia

Aleksandra Golos, MD PhD, Dorota Jesionek-Kupnicka, MD PhD, Tadeusz Robak, MD PhD, Ewa Wawrzyniak, PhD, Lidia Anna Gil, MD PhD, Mieczyslaw Komarnicki, MD PhD, Anna Wache, MD, Agnieszka Wierzbowska, MD PhD

Blood (2015) 126 (23): 3816.

https://doi.org/10.1182/blood.V126.23.3816.3816

Published: 2015

Journal Articles

Early Trafficking of Bone Marrow Derived-Endothelial Progenitor Cells Promotes Multiple Myeloma Progression

Michele Moschetta, MD, Yuji Mishima, PhD, Yawara Kawano, MD PhD, Yosra Aljawai, MS, Bruno Paiva, PhD, Luis Palomera, MD, Arianna Calcinotto, Unitt L. Christine, BSc, Ilyas Sahin, MD, Antonio Sacco, BS, Siobhan Glavey, MD, Michaela R. Reagan, PhD, Salomon Manier, MD, Peter Leif Bergsagel, MD PhD, Marta Chesi, PhD, Matteo Bellone, MD, Aldo M Roccaro, MD PhD, Irene M. Ghobrial, MD

Blood (2014) 124 (21): 4719.

https://doi.org/10.1182/blood.V124.21.4719.4719

Published: 2014

Journal Articles

The Interaction Between Collagen-Activated Platelets and Erythrocytes Selectively Increases the Release of Subsets of Platelet α-Granules Containing Pro-Angiogenic Substances

Maria Teresa Santos, PhD, Antonio Moscardo, PhD, Miguel A. Sanz, MD PhD, Ana Maria Latorre, MS, Maria Angeles Dasi, MD PhD, Juana Valles, PhD

Blood (2014) 124 (21): 4171.

https://doi.org/10.1182/blood.V124.21.4171.4171

Published: 2014

Journal Articles

Serum Platelet Factor 4 Is a Promising Therapeutic Response and Prognostic Marker in Patients with Newly Diagnosed Multiple Myeloma

Ju Bai, Aili He, Wanggang Zhang, Yun Yang, Jianli Wang, Pengyu Zhang, Yang Zhang, Lei Zhang, Liufang Gu, Jin Wang, Rui Shi, Xin Meng, Wei Tian, Xiaman Wang, Xiaoru Lei

Blood (2014) 124 (21): 2004.

https://doi.org/10.1182/blood.V124.21.2004.2004

Published: 2014

Journal Articles

Crystal structure of histidine-rich glycoprotein N2 domain reveals redox activity at an interdomain disulfide bridge: implications for angiogenic regulation

Omar Kassaar, Stephen A. McMahon, Rory Thompson, Catherine H. Botting, James H. Naismith, Alan J. Stewart

Blood (2014) 123 (12): 1948–1955.

https://doi.org/10.1182/blood-2013-11-535963

Published: 2014

Includes: Supplemental data

Journal Articles

A Systematic Review On The Use Of Pharmacological Agents In Patients With Hereditary Hemorrhagic Telangiectasia (HHT)

Mansoor Radwi, MD, Arjuna Ponnampalam, MD, Marie E Faughnan, MD, Nadine Shehata, MD, MSC

Blood (2013) 122 (21): 4745.

https://doi.org/10.1182/blood.V122.21.4745.4745

Published: 2013

Journal Articles

Identification Of Diffuse Large b-Cell Lymphoma (DLBCL) Subtypes Defined By The Expression Of Stromal Proteins and Their Association With Proangiomirs and Antiangiomirs

Natalia Morais Borges, Marina Lourenço de Conti, Tathiana Azevedo de Andrade, Maria Dirlei Begnami, Antonio Correa Alves, Gisele Wally Braga Colleoni

Blood (2013) 122 (21): 3020.

https://doi.org/10.1182/blood.V122.21.3020.3020

Published: 2013

Journal Articles

STUDY ON ANTIANGIOGENENIC EFFECT OF ACANTHOPANAX SENTICOSUS IN HL60 CELL LINES

Chen Fangyuan, Sr., M.D, Zhang Minyue, Sr., M.D, Cai Jiayi, Sr., M.D, Shen Lijing, Sr., M.D

Blood (2013) 122 (21): 4857.

https://doi.org/10.1182/blood.V122.21.4857.4857

Published: 2013

NARROW

Altered Angiogenic Gene Expression Profiles in Porcine Von Willebrand Disease

The MP0250-CP201 Mirror Study: A Phase 2 Study Update of MP0250 Plus Bortezomib and Dexamethasone in Relapse/Refractory Multiple Myeloma (RRMM) Patients Previously Exposed to Proteasome Inhibitors and Immunomodulatory Drugs

Subgroup Analyses from L-Mind, a Phase II Study of Tafasitamab (MOR208) Combined with Lenalidomide in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Venous Thromboembolism in Cancer Patients Receiving Immunotherapy

Arterial and Venous Thromboembolic Safety of Bevacizumab in Patients with High Grade Gliomas

Pomalidomide Based Regimens for Treatment of Relapsed Multiple Myeloma: A Systematic Review and Meta-Analysis of Clinical Trials

Single-Arm Phase II Study of MOR208 Combined with Lenalidomide in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma: L-Mind

Single-Arm Phase II Study of MOR208 Combined with Lenalidomide in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma: L-Mind

Role of Platelets in Adaptive Changes to Anti-Angiogenesis Therapy

Thrombospondin-1 Induces Apoptosis in Megakaryocytic Leukemia Via CD36 and Caspase-3 Signaling

VEGF , VEGFR2 and GSTM1 polymorphisms in Outcome of Multiple Myeloma Patients in the Thalidomide Era

Treatment of Hodgkin Lymphoma Xenografts with the Novel PI3K δ/γ Inhibitor RP6530 Suppresses M2 Macrophage Polarization and Results in Potent Antitumor and Antiangiogenic Effects

The Role of the Slit-Robo Family in Adult Patients with Acute Myeloid Leukemia

Early Trafficking of Bone Marrow Derived-Endothelial Progenitor Cells Promotes Multiple Myeloma Progression

The Interaction Between Collagen-Activated Platelets and Erythrocytes Selectively Increases the Release of Subsets of Platelet α-Granules Containing Pro-Angiogenic Substances

Serum Platelet Factor 4 Is a Promising Therapeutic Response and Prognostic Marker in Patients with Newly Diagnosed Multiple Myeloma

Crystal structure of histidine-rich glycoprotein N2 domain reveals redox activity at an interdomain disulfide bridge: implications for angiogenic regulation

A Systematic Review On The Use Of Pharmacological Agents In Patients With Hereditary Hemorrhagic Telangiectasia (HHT)

Identification Of Diffuse Large b-Cell Lymphoma (DLBCL) Subtypes Defined By The Expression Of Stromal Proteins and Their Association With Proangiomirs and Antiangiomirs

STUDY ON ANTIANGIOGENENIC EFFECT OF ACANTHOPANAX SENTICOSUS IN HL60 CELL LINES

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only